IP Library Assignment 056026/0273
Patent Assignment
Reel/Frame 056026/0273

Assignment of Assignor's Interest

Recorded: 2021-04-22 Pages: 6
Assignor
FRONTHERA U.S. PHARMACEUTICALS LLC
Executed: 2021-04-07
Assignee
ESKER THERAPEUTICS, INC.
4047 25TH STREET, SAN FRANCISCO, CALIFORNIA, 94114
Covered Property (1)
Substituted Pyridines as TYK2 Inhibitors
Application: 16/938,183 →
Publication: US 2020/0354338
Related Assignments (3)
Other recorded transfers of the patent in this record — the chain of ownership.
Assignment of Assignor's Interest Aug 5, 2020
From: JIN, BOHAN; DONG, QING; HUNG, GENE; KALDOR, STEPHEN W.
To: FRONTHERA U.S. PHARMACEUTICALS LLC
Reel/Frame 053415/0156 →
Release of Security Interest Mar 8, 2021
From: HAISCO PHARMACEUTICAL CO., LIMITED
To: FRONTHERA U.S. PHARMACEUTICALS LLC; FRONTHERA INTERNATIONAL GROUP LIMITED
Reel/Frame 055528/0734 →
Change of Name Feb 10, 2022
From: ESKER THERAPEUTICS, INC.
To: ALUMIS INC.
Reel/Frame 059009/0623 →